Updates of the Belgian List of reimbursable devices in February 2026

In February 2026, the Belgian National Institute for Health and Disability Insurance (INAMI/RIZIV) updated the List of implants and invasive medical devices. The devices on the List are allocated to the material code and tariff (fee-for-service), which allows hospitals to receive reimbursement.

One new material code was added to the List:

• 187095-187106 “Invasive ablation device for percutaneous cryoablation of desmoid tumors, per unit, including accessories”.

Furthermore, Nominative lists were updated in February 2026. These lists specify certain brands in connection with material codes on the List of implants and invasive medical devices, when brand-specific registration is required.

A number of new devices were added in the cardiovascular, neuromodulation, and orthopedic fields.

• For example, two deep brain stimulation devices by Boston Scientific were added to the Nominative list 359 “Neurostimulators and accessories in movement disorders”. 

See the full details in French here and in Dutch here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.